Differential vasodilation response to olprinone in rabbit renal and common carotid arteries

[1]  Y. Hatano,et al.  The Mechanism Behind the Inhibitory Effect of Isoflurane on Angiotensin II-Induced Vascular Contraction Is Different from That of Sevoflurane , 2007, Anesthesia and analgesia.

[2]  K. Mizushige,et al.  The effects of olprinone, a phosphodiesterase 3 inhibitor, on systemic and cerebral circulation. , 2006, Current vascular pharmacology.

[3]  真徳 尾野本.  Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries , 2005 .

[4]  于金贵.  Sevoflurane inhibits angiotensin II-induced, protein kinase C-mediated, not Ca^2＋ -elicited, contraction of rat aortic smooth muscle , 2005 .

[5]  S. Nishi,et al.  Pharmacokinetics and pharmacodynamics of olprinone after cardiac surgery. , 2004, Osaka city medical journal.

[6]  M. Movsesian.  PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider. , 2003, Journal of cardiac failure.

[7]  JinGui Yu,et al.  Sevoflurane Inhibits Guanosine 5′-[&ggr;-thio]triphosphate–stimulated, Rho/Rho-kinase–mediated Contraction of Isolated Rat Aortic Smooth Muscle , 2003, Anesthesiology.

[8]  K. Mizushige,et al.  Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects. , 2006, Cardiovascular drug reviews.

[9]  H. Derouet,et al.  Involvement of cyclic nucleotides in renal artery smooth muscle relaxation , 2003, Urological Research.

[10]  Y. Kakihana,et al.  The Effects of Olprinone (a Phosphodiesterase III Inhibitor) on Hepatic Vascular Bed in a Porcine Model of Endotoxemia , 2001 .

[11]  O. Kemmotsu,et al.  Phosphodiesterase III inhibitor olprinone chlorate is not significantly removed by continuous venovenous hemodiafiltration. , 2000, ASAIO journal.

[12]  G. Iribe,et al.  Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism , 2000, Critical care medicine.

[13]  白石 良久.  Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine-induced increase in [Ca²⁺]i and force in middle cerebral artery of the rabbit , 1999 .

[14]  T. Itoh,et al.  Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits. , 1998, European journal of pharmacology.

[15]  T. Itoh,et al.  Effect of cilostazol, a phosphodiesterase type III inhibitor, on histamine‐induced increase in [Ca2+]i and force in middle cerebral artery of the rabbit , 1998, British journal of pharmacology.

[16]  H. Iwasaka,et al.  [Effects of loprinone hydrochloride on hemodynamics and respiratory oxygenation in patients after cardiac surgery]. , 1997, Masui. The Japanese journal of anesthesiology.

[17]  J. Beavo,et al.  Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.

[18]  C. Lugnier,et al.  Endothelium‐dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors , 1991, British journal of pharmacology.

[19]  K. Andersson,et al.  Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat. , 1991, Acta physiologica Scandinavica.

[20]  P. Silver,et al.  Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries , 1989, Journal of cardiovascular pharmacology.

[21]  R. Bentley,et al.  Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. , 1988, European journal of pharmacology.

[22]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.